Beta2-agonist Impairs Muscle Insulin Sensitivity in Persons With Insulin Resistance
The Journal of Clinical Endocrinology & Metabolism · 2024
DOI: 10.1210/clinem/dgae381 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2024. Verfasst von Johan Onslev und 7 weiteren Autor:innen. Beteiligte Einrichtung: August Krogh Section for Molecular Physiology, Department of Nutrition, Exercise and Sports, University of Copenhagen, 2100 Copenhagen, Denmark. Hauptthemen laut MEDLINE: Insulin Resistance, Muscle, Skeletal, Cross-Over Studies, Glucose Clamp Technique. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 47 Literaturangaben. Gefördert von: Danish Ministry of Culture, Danish Diabetes and Endocrine Academy, Novo Nordisk Foundation.
Abstract (Originalsprache)
Context
Given the promising effects of prolonged treatment with beta2-agonist on insulin sensitivity in animals and nondiabetic individuals, the beta2-adrenergic receptor has been proposed as a target to counter peripheral insulin resistance. On the other hand, rodent studies also reveal that beta2-agonists acutely impair insulin action, posing a potential caveat for their use in treating insulin resistance.
Objective
To assess the impact of beta2-agonist on muscle insulin action and glucose metabolism and identify the underlying mechanism(s) in 10 insulin-resistant subjects. Methods and participants In a crossover design, we assessed the effect of beta2-agonist on insulin-stimulated muscle glucose uptake during a 3-hour hyperinsulinemic isoglycemic clamp with and without intralipid infusion in 10 insulin-resistant, overweight subjects. Two hours into the clamp, we infused beta2-agonist. We collected muscle biopsies before, 2 hours into, and by the end of the clamp and analyzed them using metabolomic and lipidomic techniques.
Results
We establish that beta2-agonist, independently from and additively to intralipid, impairs insulin-stimulated muscle glucose uptake via different mechanisms. In combination, beta2-agonist and intralipid nearly eliminates insulin-dependent muscle glucose uptake. Although both beta2-agonist and intralipid elevated muscle glucose-6-phosphate, only intralipid caused accumulation of downstream muscle glycolytic intermediates, whereas beta2-agonist attenuated incorporation of glucose into glycogen.
Conclusion
Our findings suggest that beta2-agonist inhibits glycogenesis, whereas intralipid inhibits glycolysis in skeletal muscle of insulin-resistant individuals. These results should be addressed in future treatment of insulin resistance with beta2-agonist.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- August Krogh Section for Molecular Physiology, Department of Nutrition, Exercise and Sports, University of Copenhagen, 2100 Copenhagen, Denmark.
- August Krogh Section for Human Physiology, Department of Nutrition, Exercise and Sports, University of Copenhagen, 2100 Copenhagen, Denmark.
- Department of Biochemistry and Molecular Biology, University of Southern Denmark, 5230 Odense, Denmark.
ORCID-Profile: Johan Onslev, Matteo Fiorenza, Martin Thomassen, Jesper Havelund, Jørgen F P Wojtaszewski, Morten Hostrup
Förderung
- Danish Ministry of Culture
- Danish Diabetes and Endocrine Academy
- Novo Nordisk Foundation
Zitieren
APA
Onslev, J., Fiorenza, M., Thomassen, M., Havelund, J., Bangsbo, J., Færgeman, N., Wojtaszewski, J. F. P., & Hostrup, M. (2024). Beta2-agonist Impairs Muscle Insulin Sensitivity in Persons With Insulin Resistance. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgae381
Vancouver
Onslev J, Fiorenza M, Thomassen M, Havelund J, Bangsbo J, Færgeman N, et al. Beta2-agonist Impairs Muscle Insulin Sensitivity in Persons With Insulin Resistance. The Journal of Clinical Endocrinology & Metabolism. 2024. doi:10.1210/clinem/dgae381
BibTeX
@article{Onslev2024,
author = {Onslev, Johan and Fiorenza, Matteo and Thomassen, Martin and Havelund, Jesper and Bangsbo, Jens and Færgeman, Nils and Wojtaszewski, Jørgen F P and Hostrup, Morten},
title = {Beta2-agonist Impairs Muscle Insulin Sensitivity in Persons With Insulin Resistance},
journal = {The Journal of Clinical Endocrinology & Metabolism},
year = {2024},
doi = {10.1210/clinem/dgae381}
}
EUVIMED